Even if it is Brentford!
GlaxoSmithKline will be run directly from London for the first time since its creation in 2001 following the assumption of the chief executive’s role by Andrew Witty in May.
Mr Witty, formerly GSK’s president of European pharmaceuticals, will remain at the group’s Brentford office in his new role in what is a significant change of corporate structure. JP Garnier, the current chief, has been based at the company’s US headquarters in Philadelphia.
GlaxoSmithKline will be run directly from London for the first time since its creation in 2001 following the assumption of the chief executive’s role by Andrew Witty in May.
Mr Witty, formerly GSK’s president of European pharmaceuticals, will remain at the group’s Brentford office in his new role in what is a significant change of corporate structure. JP Garnier, the current chief, has been based at the company’s US headquarters in Philadelphia.
The US, where GSK employs 25,000 staff, generates roughly half of the annual sales of £20 billion.
A spokesman said Mr Witty will remain in the UK, partly for family reasons. He emphasised that there would be no significant relocation of staff or resources from Philadelphia to Britain. He added that Mr Witty would visit the US frequently and said that GSK would continue to operate a “dual headquarters” split between the two cities.
Times
No comments:
Post a Comment